CA2148007A1 - Extraits allergeniques - Google Patents
Extraits allergeniquesInfo
- Publication number
- CA2148007A1 CA2148007A1 CA002148007A CA2148007A CA2148007A1 CA 2148007 A1 CA2148007 A1 CA 2148007A1 CA 002148007 A CA002148007 A CA 002148007A CA 2148007 A CA2148007 A CA 2148007A CA 2148007 A1 CA2148007 A1 CA 2148007A1
- Authority
- CA
- Canada
- Prior art keywords
- allergenic
- extract
- extraction
- extraction step
- extracts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000284 extract Substances 0.000 title claims abstract description 111
- 230000002009 allergenic effect Effects 0.000 title claims abstract description 73
- 238000000605 extraction Methods 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 47
- 239000000463 material Substances 0.000 claims abstract description 33
- 238000009169 immunotherapy Methods 0.000 claims abstract description 20
- 238000012544 monitoring process Methods 0.000 claims abstract description 7
- 208000026278 immune system disease Diseases 0.000 claims abstract description 6
- 230000008569 process Effects 0.000 claims description 12
- 230000002378 acidificating effect Effects 0.000 claims description 9
- 230000002045 lasting effect Effects 0.000 claims description 9
- 208000026935 allergic disease Diseases 0.000 claims description 8
- 239000003125 aqueous solvent Substances 0.000 claims description 5
- 230000002163 immunogen Effects 0.000 claims description 5
- 239000003929 acidic solution Substances 0.000 claims description 4
- 239000012670 alkaline solution Substances 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 7
- 230000000172 allergic effect Effects 0.000 abstract description 12
- 208000010668 atopic eczema Diseases 0.000 abstract description 12
- 238000002360 preparation method Methods 0.000 abstract description 7
- 238000003745 diagnosis Methods 0.000 abstract description 6
- 238000013459 approach Methods 0.000 abstract description 5
- 230000009897 systematic effect Effects 0.000 abstract description 5
- 230000000890 antigenic effect Effects 0.000 abstract description 4
- 230000003389 potentiating effect Effects 0.000 abstract description 2
- 239000013566 allergen Substances 0.000 description 34
- 229960004784 allergens Drugs 0.000 description 28
- 239000000706 filtrate Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000287 crude extract Substances 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 230000007815 allergy Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 210000000612 antigen-presenting cell Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 241000219430 Betula pendula Species 0.000 description 1
- 240000004585 Dactylis glomerata Species 0.000 description 1
- 241000238740 Dermatophagoides pteronyssinus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000221535 Pucciniales Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000221561 Ustilaginales Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229940074608 allergen extract Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940046528 grass pollen Drugs 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940046536 tree pollen allergenic extract Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92203367.5 | 1992-11-03 | ||
| EP92203367 | 1992-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2148007A1 true CA2148007A1 (fr) | 1994-05-11 |
Family
ID=8211014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002148007A Abandoned CA2148007A1 (fr) | 1992-11-03 | 1993-11-03 | Extraits allergeniques |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0667788A1 (fr) |
| JP (1) | JPH08505126A (fr) |
| AU (1) | AU682669B2 (fr) |
| CA (1) | CA2148007A1 (fr) |
| WO (1) | WO1994009824A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1834648B1 (fr) * | 2006-03-14 | 2013-07-31 | Alk-Abelló A/S | Procédé pour la préparation d'un extrait d'allergène |
| EP1834649A1 (fr) * | 2006-03-14 | 2007-09-19 | Alk-Abello A/S | Méthode pour développer un procédé pour la préparation d'un extrait d'allergène |
| US7887821B2 (en) | 2007-12-20 | 2011-02-15 | Alk-Abello A/S | Process for producing an allergen extract |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7316346A (fr) * | 1972-12-11 | 1974-06-13 | ||
| US4364938A (en) * | 1981-02-13 | 1982-12-21 | Hoek Gijsberk T | Production of immunogenic products and treatment of allergic reactions therewith |
-
1993
- 1993-11-03 CA CA002148007A patent/CA2148007A1/fr not_active Abandoned
- 1993-11-03 WO PCT/EP1993/003041 patent/WO1994009824A1/fr not_active Application Discontinuation
- 1993-11-03 JP JP6510713A patent/JPH08505126A/ja active Pending
- 1993-11-03 AU AU53726/94A patent/AU682669B2/en not_active Expired - Fee Related
- 1993-11-03 EP EP93924086A patent/EP0667788A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU5372694A (en) | 1994-05-24 |
| EP0667788A1 (fr) | 1995-08-23 |
| AU682669B2 (en) | 1997-10-16 |
| WO1994009824A1 (fr) | 1994-05-11 |
| JPH08505126A (ja) | 1996-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4234569A (en) | Production of aldehyde-treated allergen-containing substances | |
| AU682669B2 (en) | Allergenic extracts | |
| US3577523A (en) | Water-insoluble antigenic substances and method of preparing the same and antigenic depot agents incorporating such substances | |
| JP3790099B2 (ja) | 天然アレルゲンの寛容原性断片 | |
| EP0173889B1 (fr) | Immunoamplificateurs et procédés pour leur extraction | |
| JPH02138130A (ja) | 重合されたアレルゲンの製造方法 | |
| DE2658170A1 (de) | Arzneimittel zur behandlung der durch den hepatitisvirus b ausgeloesten akuten oder chronischen infektionen | |
| RU97108362A (ru) | Главный белок cd внешней мембраны moraxella | |
| JP3397791B2 (ja) | アレルゲンとして活性なタンパク質を含有する水性エキスの精製方法，この方法で得られるエキスならびにそれらの使用 | |
| Sutherland | THE SYDNEY FUNNEL–WEB SPIDER (ATRAX ROBUSTUS) 2. FRACTIONATION OF THE FEMALE VENOM INTO FIVE DISTINCT COMPONENTS | |
| Richter et al. | Studies on the allergens of ragweed pollen: A review | |
| US3591677A (en) | Allergenic extract and process for preparing same | |
| US3148121A (en) | Water-insoluble whole inhalant complex and method of making same | |
| Kuo et al. | A new allergen from the perienteric fluid of Ascaris suum with respect to charges | |
| US3629397A (en) | Therapeutic and diagnostic allergenic extracts and process for preparing same | |
| US3148122A (en) | Water-insoluble whole pollen complex and method of making same | |
| US3798319A (en) | Therapeutic and diagnostic allergenic extract and process for preparing same | |
| RU2809823C2 (ru) | Способы очистки экстракта аллергена | |
| US20220079999A1 (en) | Antivenom compositions and uses thereof | |
| Coulson et al. | The Immunochemistry of Allergens: V. Comparison of the Rates of Dialysis of Crystalline Ovalbumin and of the Cottonseed Allergen, CS-1A | |
| RU2287345C2 (ru) | Средство для стимуляции выработки фактора viii свертывания крови | |
| RU2077340C1 (ru) | Способ получения специфической сыворотки для лечения, диагностики и профилактики вирусной геморрагической болезни кроликов и набор для диагностики болезни | |
| DE2815758A1 (de) | Peptidkomplexe aus dns-haltigen organismen | |
| Shonle | The preparation and chemistry of insulin | |
| Kildruffe et al. | Effect of blood preservatives on urea determination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |